相关实验视频
Updated: Jan 17, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
909
肥胖及其并发症:当前的治疗选择,新兴的生物机制,未来的前景和挑战
Lihua Wang1,2, Qian Wang3, Yumo Xiong4
1Institute of Acupuncture and Moxibustion, Department of Medicine, Jianghan University, Wuhan, People's Republic of China.
Diabetes, metabolic syndrome and obesity : targets and therapy
|September 18, 2025
概括
肥胖是一种复杂的疾病,增加了健康风险. 新的研究探讨了有效的体重管理和治疗相关疾病的潜在机制和潜在的精准医学目标.
科学领域:
- 代谢性疾病研究研究.
- 公共卫生挑战 公共卫生挑战
背景情况:
- 肥胖是一种慢性多因子疾病,对全球健康有重大影响.
- 它增加了2型糖尿病 (T2DM),心血管疾病,心力衰竭和与代谢功能障碍相关的脂肪性肝病的风险.
- 目前的治疗方法面临着药物安全性方面的挑战,手术干预只适用于高级病例.
研究的目的:
- 综合审查肥胖及其伴随疾病的流行病学.
- 分析对驱动肥胖引起的慢性并发症机制的最新见解.
- 确定肥胖管理的新兴治疗目标.
主要方法:
- 对流行病学数据的文献综述.
- 对最近关于肥胖病理生理学的研究进行分析.
- 综合关于新型治疗策略的证据.
主要成果:
- 肥胖与脂肪组织的失衡,肠道微生物群的失调和免疫系统功能障碍有关.
- 这些因素有助于与肥胖相关的慢性并发症.
- 新兴的见解揭示了许多潜在的减肥治疗点.
结论:
- 了解肥胖的复杂机制是开发有效治疗的关键.
- 信号传导途径的进步可能使未来的多式联络和精准医学方法成为可能.
- 进一步研究新的目标和途径对于管理肥胖及其并发性疾病至关重要.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Coronary Artery Disease I: Introduction
890
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
890

